Tuesday, 02 January 2024 12:17 GMT

Avant Technologies Inc


(MENAFN- Baystreet) 10:40 AM EST - Avant Technologies Inc: Announced a newly published study from the Mayo Clinic reinforces the critical role of the“longevity protein” a-Klotho in vascular health and aging. The research, appearing in the Journal of the American Heart Association, demonstrates a strong association between declining a-Klotho levels and arterial stiffness, endothelial dysfunction, vascular calcification, and significantly reduced patient survival. Avant Technologies Inc shares O are trading unchanged at $0.29.

Full Press Release:

MENAFN09122025000212011056ID1110460301



Baystreet.ca

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search